HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J S Smolen Selected Research

canakinumab

6/2018ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J S Smolen Research Topics

Disease

55Rheumatoid Arthritis
09/2020 - 01/2000
13Necrosis
09/2020 - 07/2000
13Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2012 - 08/2000
6Disease Progression
05/2014 - 06/2000
6Arthritis (Polyarthritis)
07/2013 - 01/2001
5Osteoarthritis
03/2020 - 01/2000
5Rheumatic Diseases (Rheumatism)
01/2017 - 11/2004
5Inflammation (Inflammations)
07/2013 - 05/2001
3Psoriatic Arthritis
03/2016 - 01/2012
3Joint Diseases (Joint Disease)
06/2007 - 11/2000
3Pain (Aches)
05/2004 - 02/2000
2Infections
06/2018 - 10/2006
2Injection Site Reaction
07/2009 - 10/2006
2Nausea
10/2006 - 09/2001
2Proteinuria
07/2005 - 01/2001
2Glomerulonephritis
01/2005 - 05/2004
2Acute-Phase Reaction
01/2004 - 12/2002
2Mixed Connective Tissue Disease (MCTD)
07/2002 - 08/2000
2Alopecia (Baldness)
09/2001 - 06/2000
2Autoimmune Diseases (Autoimmune Disease)
04/2001 - 10/2000
1Candidiasis (Moniliasis)
06/2018
1Communicable Diseases (Infectious Diseases)
06/2018
1Latent Tuberculosis
06/2018
1Ankylosing Spondylitis
01/2014
1Axial Spondyloarthritis
01/2014
1Connective Tissue Diseases (Connective Tissue Disease)
01/2014
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2014
1Experimental Arthritis
01/2012
1Tuberculosis (Tuberculoses)
06/2010
1Bacterial Infections (Bacterial Infection)
06/2010
1Pharyngitis (Sore Throat)
07/2009
1Laryngitis
07/2009
1Amyloidosis
11/2008
1Asthenia
10/2006
1Headache (Headaches)
10/2006

Drug/Important Bio-Agent (IBA)

19Antirheumatic Agents (DMARD)IBA
05/2015 - 06/2000
10Methotrexate (Mexate)FDA LinkGeneric
06/2009 - 06/2000
9CytokinesIBA
01/2010 - 10/2000
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009 - 11/2000
8AutoantibodiesIBA
07/2013 - 01/2000
7Sulfasalazine (Azulfidine)FDA LinkGeneric
07/2009 - 06/2000
6Infliximab (Remicade)FDA Link
05/2014 - 11/2000
6Leflunomide (Arava)FDA LinkGeneric
10/2003 - 06/2000
4Interleukin-1 (Interleukin 1)IBA
06/2018 - 02/2001
3Etanercept (Enbrel)FDA Link
03/2020 - 10/2006
3InterleukinsIBA
06/2018 - 10/2000
3GlucocorticoidsIBA
06/2010 - 07/2005
2Immunoglobulins (Immunoglobulin)IBA
06/2018 - 07/2005
2Tumor Necrosis Factor InhibitorsIBA
02/2017 - 03/2016
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 05/2001
2Antinuclear AntibodiesIBA
01/2014 - 01/2001
2Immunoglobulin G (IgG)IBA
07/2013 - 07/2005
2Abatacept (Orencia)FDA Link
03/2013 - 04/2009
2Monoclonal AntibodiesIBA
06/2010 - 11/2000
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
11/2005 - 11/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2005 - 05/2004
2Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
07/2002 - 08/2000
2Proteins (Proteins, Gene)FDA Link
07/2002 - 12/2000
2AntibodiesIBA
07/2002 - 11/2000
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2002 - 01/2001
2EnzymesIBA
08/2001 - 06/2000
2Interleukin-2 (IL2)IBA
08/2001 - 04/2001
1Biosimilar PharmaceuticalsIBA
09/2020
1Interleukin-12 (IL 12)IBA
06/2018
1mepolizumabIBA
06/2018
1eculizumabFDA Link
06/2018
1tocilizumab (atlizumab)FDA Link
06/2018
1siltuximabIBA
06/2018
1rilonaceptFDA Link
06/2018
1canakinumabFDA Link
06/2018
1ixekizumabIBA
06/2018
1secukinumabIBA
06/2018
1brodalumabIBA
06/2018
1Ustekinumab (CNTO 1275)FDA Link
06/2018
1Antiviral Agents (Antivirals)IBA
06/2018
1Complement System Proteins (Complement)IBA
06/2018
1Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
06/2018
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2018
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2017
1Certolizumab PegolFDA Link
05/2015
1pristane (pristan)IBA
07/2013
1Immunoglobulin M (IgM)IBA
07/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2012
1Heme Oxygenase-1IBA
01/2012
1Heme (Haem)IBA
01/2012
1Carbon MonoxideIBA
01/2012
1IronIBA
01/2012
1Biliverdine (Biliverdin)IBA
01/2012
1InterferonsIBA
01/2009
1Histones (Histone)IBA
01/2009
1ametantrone (HAQ)IBA
02/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2008
1Anabolic AgentsIBA
06/2007
1Rituximab (Mabthera)FDA Link
02/2007

Therapy/Procedure

24Therapeutics
03/2020 - 07/2000
2Drug Therapy (Chemotherapy)
01/2002 - 01/2001
1Biological Therapy
06/2018
1Chemoprevention
06/2018
1Renal Dialysis (Hemodialysis)
11/2008